4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cellectar Biosciences, Inc. (CLRB) operates in the Biotechnology industry and is headquartered in Florham Park, United States with about 11 employees. Its market capitalization is roughly $21 million. In the fiscal year ended 2025-12-31, CLRB reported $0M in revenue and ($22M) in net income.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($23M) | ($52M) | ($39M) | ($29M) | — |
| Net Income | ($22M) | ($45M) | ($43M) | ($32M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($6M) | ($5M) | ($6M) | ($6M) | — |
| Net Income | ($6M) | ($5M) | ($4M) | ($5M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $15M | $26M | $12M | $22M | — |
| Total Liabilities | $6M | $11M | $27M | $13M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CLRB viewer.
About TickerBase · Data methodology & sources